Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Oct 4 - Oct 9
The \$60 to \$120 spread across chains looks meaningful in absolute dollars but is only 5% to 9% of a \$1,400 prescription
Only one SAE was deemed unlikely related to the intervention, with the rest deemed not related
The company's application includes data supporting the safety and efficacy of their generic formulation
The main difference is what they are approved for and their dosing
extensive post-market safety data Advantage : Tirzepatide Liver Fat Reduction# Retatrutide : Significant hepatic fat reduction via glucagon receptor activation (up to 82% reduction) Tirzepatide : Moderate hepatic fat reduction observed in trials Advantage : Retatrutide Dosing Convenience# Retatrutide : Once-weekly subcutaneous injection Tirzepatide : Once-weekly subcutaneous injection with established titration schedule Advantage : Neither (tie) Summary and Verdict# Tirzepatide is the proven choice with FDA approval and extensive clinical data
US$ 29.56
US$ 25.76
US$ 27.71
US$ 23.46
